nicotine has been researched along with acamprosate in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aistrup, GL; Engel, JA; Ericson, M; Hedlund, L; Kalouti, U; Marszalec, W; Narahashi, T; Nordberg, A; Olausson, P; Schmidt, LG; Smolka And, M; Söderpalm, B; Zhang, X | 1 |
Beilby, JJ; Doran, CM; Duszynski, KM; Mattick, RP | 1 |
Diehl, A; Mann, K | 1 |
Spangler, JG | 1 |
Bholat, Y; Farrokhi, C; Lacayo, LM; Manalo, CM; Pechnick, RN; Reyes, KC; Spivak, I; Vit, JP | 1 |
Goutier, W; Kloeze, M; McCreary, AC | 1 |
2 review(s) available for nicotine and acamprosate
Article | Year |
---|---|
Mechanisms of alcohol-nicotine interactions: alcoholics versus smokers.
Topics: Acamprosate; Acetylcholine; Alcohol Deterrents; Alcoholism; Animals; Central Nervous System Depressants; Drug Interactions; Ethanol; Gene Expression; Humans; Male; Nicotine; Nicotinic Agonists; Rats; Receptors, Nicotinic; Reinforcement, Psychology; Secondary Prevention; Smoking; Taurine; Vasodilator Agents; Ventral Tegmental Area | 2001 |
[Pharmacological relapse prevention in alcohol and tobacco dependence].
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Clinical Trials as Topic; Combined Modality Therapy; Disulfiram; Humans; Naltrexone; Nicotine; Psychotherapy; Secondary Prevention; Smoking Cessation; Substance Withdrawal Syndrome; Taurine; Tobacco Use Disorder | 2007 |
4 other study(ies) available for nicotine and acamprosate
Article | Year |
---|---|
Use of pharmacotherapies for the management of addictive behaviours in Australian clinical practice.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Australia; Bupropion; Dopamine Uptake Inhibitors; Female; Health Care Surveys; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Substance-Related Disorders; Taurine; Tobacco Use Disorder | 2006 |
NMDA receptor blockade: a novel avenue for tobacco intervention?
Topics: Acamprosate; Central Nervous System Stimulants; Humans; Memantine; Models, Biological; Models, Theoretical; Neurons; Nicotiana; Nicotine; Prefrontal Cortex; Receptors, N-Methyl-D-Aspartate; Smoking Cessation; Taurine | 2008 |
Acamprosate attenuates cue-induced reinstatement of nicotine-seeking behavior in rats.
Topics: Acamprosate; Animals; Cues; Drug-Seeking Behavior; Male; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Self Administration; Taurine | 2011 |
Nicotine-induced locomotor sensitization: pharmacological analyses with candidate smoking cessation aids.
Topics: Acamprosate; Analysis of Variance; Animals; Antidiuretic Hormone Receptor Antagonists; Bupropion; Dose-Response Relationship, Drug; Fructose; Indoles; Male; Motor Activity; Naltrexone; Nicotine; Nicotinic Agonists; Pyrrolidines; Rats, Wistar; Taurine; Tobacco Use Cessation Devices; Topiramate | 2016 |